跳转至内容
Merck
CN

258113

硝酸

ACS reagent, 70%

登录 查看组织和合同定价。

选择尺寸

变更视图

关于此项目

经验公式(希尔记法):
HNO3
化学文摘社编号:
分子量:
63.01
NACRES:
NA.21
PubChem Substance ID:
UNSPSC Code:
12352106
MDL number:
Assay:
68.0-70.0% (ACS specification), 70%
Grade:
ACS reagent
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助


grade

ACS reagent

Quality Level

vapor density

1 (vs air)

vapor pressure

8 mmHg ( 20 °C)

assay

68.0-70.0% (ACS specification), 70%

ign. residue

≤5 ppm

color

APHA: ≤10

bp

120.5 °C (lit.)

density

1.413 g/mL at 25 °C

anion traces

chloride (Cl-): ≤0.5 ppm, sulfate (SO42-): ≤1 ppm

cation traces

As: ≤0.01 ppm, Fe: ≤0.2 ppm, heavy metals (as Pb): ≤0.2 ppm

SMILES string

O[N+]([O-])=O

InChI

1S/HNO3/c2-1(3)4/h(H,2,3,4)

InChI key

GRYLNZFGIOXLOG-UHFFFAOYSA-N

General description

二溴甲烷-d2是一种氘代NMR溶剂,可用于基于NMR的研究和分析。

Application

二溴甲烷-d2可用于合成[18F]?氟甲基溴-d2。该化合物可用于 N-(3,5-二氯苄基)-4-羟基苯甲酰亚胺的烷基化,以形成可用于PET成像研究的?氟-18标记的示踪剂。


Still not finding the right product?

Explore all of our products under 硝酸


signalword

Danger

Hazard Classifications

Acute Tox. 3 Inhalation - Eye Dam. 1 - Met. Corr. 1 - Ox. Liq. 3 - Skin Corr. 1A

supp_hazards

存储类别

5.1B - Oxidizing hazardous materials

wgk

WGK 1

flash_point_f

Not applicable

flash_point_c

Not applicable

法规信息

新产品

此项目有



历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库



The synthesis of a benzamidine?containing NR2B?selective NMDA receptor ligand labelled with tritium or fluorine?18.
Hamill TG, et al
Journal of Labelled Compounds & Radiopharmaceuticals, 48(1), 1-10 (2005)
Nicole McGowan et al.
The Science of the total environment, 494-495, 177-186 (2014-07-22)
Microchemical analysis of otolith (calcified 'ear stones' used for balance and orientation) of fishes is an important tool for studying their environmental history and management. However, the spatial resolution achieved is often too coarse to examine short-term events occurring in
Lauren E Kremer et al.
Journal of inorganic biochemistry, 147, 227-234 (2015-05-11)
Uncontrolled reactions in biological media are a main obstacle for clinical translation of V-based anti-diabetic or anti-cancer pro-drugs. We investigated the use of controlled-release pharmaceutical formulations to ameliorate this issue with a series of V(V) and (IV) complexes of anionic